Skip to main content
. 2010 Jul 5;28(34):5591–5596. doi: 10.1016/j.vaccine.2010.06.031

Table 1.

Summary of laboratory testing performed in pneumonia cases, ILI cases and healthy recruits.

Pathogen (identification method) Specimen tested ILI and Pneumonia cases (n = 34)a Healthy recruits (n = 562)a
Streptococcus pneumoniae (culture) Respiratory secretion/blood 5/14b –/–
Oropharyngeal/nasopharyngeal swabs –/– 55/124
Mycoplasma pneumoniae (PCR) Pharyngeal swabs 1/4 0/14
M. pneumoniae (serology) Serum 1/16 0/4
Legionella pneumophila type 1 (urine antigen) Urine 0/8 0/14
L. pneumophila (serology) Serum 0/14 0/4
RSV, influenza A and B, parainfluenza, adenovirus (IFA) Nasal swabs/sputum 0/15 0/14
Human Metapneumovirus (PCR) Nasal swabs 0/4 1/14
Chlamydophila pneumoniae (PCR) Nasal swabs 0/9 0/14
C. pneumoniae (serology) Serum 2/12
Q fever (serology) Serum 0/7
Streptococcus pyogenes (culture) Pharyngeal swabs 1/15 2/124
a

No. positive/no. tested.

b

Two patients with positive blood cultures, two with positive respiratory secretion cultures and one partially treated patient with gram-positive diplococci in sputum gram staining—all among the 15 pneumonia cases.